Literature DB >> 22965167

Ethics: Genetic testing for MEN1--whose responsibility?

Cornelis J M Lips, Jo W M Höppener.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22965167     DOI： 10.1038/nrendo.2012.164

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  9 in total

1.  Confidentiality and sharing genetic information with relatives.

Authors:  Anneke Lucassen; Michael Parker
Journal:  Lancet       Date:  2010-05-01       Impact factor: 79.321

Review 2.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).

Authors:  Rajesh V Thakker; Paul J Newey; Gerard V Walls; John Bilezikian; Henning Dralle; Peter R Ebeling; Shlomo Melmed; Akihiro Sakurai; Francesco Tonelli; Maria Luisa Brandi
Journal:  J Clin Endocrinol Metab       Date:  2012-06-20       Impact factor: 5.958

3.  Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder.

Authors:  G K Suthers; J Armstrong; J McCormack; D Trott
Journal:  J Med Genet       Date:  2005-12-21       Impact factor: 6.318

4.  A summary of the methods that the National Clinical Guideline Centre uses to produce clinical guidelines for the National Institute for Health and Clinical Excellence.

Authors:  Jennifer Hill; Ian Bullock; Phil Alderson
Journal:  Ann Intern Med       Date:  2011-06-07       Impact factor: 25.391

5.  Improving clinical practice guidelines--the answer is more clinical research.

Authors:  Stan Deresinski; Thomas M File
Journal:  Arch Intern Med       Date:  2011-08-08

6.  Families' experience of oncogenetic counselling: accounts from a heterogeneous hereditary cancer risk population.

Authors:  Álvaro Mendes; Liliana Sousa
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

7.  Individualized guidelines: the potential for increasing quality and reducing costs.

Authors:  David M Eddy; Joshua Adler; Bradley Patterson; Don Lucas; Kurt A Smith; Macdonald Morris
Journal:  Ann Intern Med       Date:  2011-05-03       Impact factor: 25.391

8.  Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.

Authors:  C J Lips; R M Landsvater; J W Höppener; R A Geerdink; G Blijham; J M van Veen; A P van Gils; M J de Wit; R A Zewald; M J Berends
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

9.  Increased genetic counseling support improves communication of genetic information in families.

Authors:  Laura E Forrest; Jo Burke; Sonya Bacic; David J Amor
Journal:  Genet Med       Date:  2008-03       Impact factor: 8.822
  9 in total
  2 in total

1.  The Research Landscape of Multiple Endocrine Neoplasia Type 1 (2000-2021): A Bibliometric Analysis.

Authors:  Chenzhe Feng; Haolin Chen; Leyi Huang; Yeqian Feng; Shi Chang
Journal:  Front Med (Lausanne)       Date:  2022-04-08

Review 2.  A differential diagnosis of inherited endocrine tumors and their tumor counterparts.

Authors:  Sergio P A Toledo; Delmar M Lourenço; Rodrigo A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2013-07       Impact factor: 2.365
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.